Genetic variants of ANGPT1, CD39, FGF2 and MMP9 linked to clinical outcome of bevacizumab plus chemotherapy for metastatic colorectal cancer

  1. Gaibar, M.
  2. Galán, M.
  3. Romero-Lorca, A.
  4. Antón, B.
  5. Malón, D.
  6. Moreno, A.
  7. Fernández-Santander, A.
  8. Novillo, A.
Aldizkaria:
International Journal of Molecular Sciences

ISSN: 1422-0067 1661-6596

Argitalpen urtea: 2021

Alea: 22

Zenbakia: 3

Orrialdeak: 1-16

Mota: Artikulua

DOI: 10.3390/IJMS22031381 GOOGLE SCHOLAR lock_openSarbide irekia editor